Apple hit with $634 million fine over smartwatch tech
A US jury just ordered Apple to pay $634 million to Masimo, saying Apple's smartwatch blood-oxygen reading technology infringed Masimo's patented pulse oximetry technology.
The November 14 verdict marks a big moment for wearable medical gadgets, putting the spotlight on how companies compete and protect their ideas.
What went down—and what's next
Instead of just asking for cash, Masimo pushed for a ban on some Apple Watch sales in the retrial, showing how high the stakes are in this tech turf war.
Earlier, US trade officials even blocked imports of certain Apple Watch models after siding with Masimo.
While Apple tried tweaking its software and got new watches cleared by customs, Masimo is still fighting back in court—reminding everyone that patent battles can shape what gadgets we get to use.